loader

Candel Therapeutics

NASDAQ:CADL

Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Featured Articles and Interviews

Top 5 Small-cap Biotech Stocks of 2025

Press Releases
At Candel Therapeutics, our team is developing viral immunotherapies that light up and empower the immune system to fight cancer

Interactive Chart

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies. 

×
×